Kenkare-Mitra Sara, President and Head of R&D at Alector, Inc. ($ALEC), sold shares on the open market three times in the last 365 days, totaling nearly $138,000. Her most recent sale occurred on December 3, 2025. These sales rank her 9,117th among 11,678 insiders in our database by total sold amount, well below the average of $8.6 million across roughly 6.4 transactions per insider. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 3, 2025 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 41687 | $1.12 | 501,652.0000 | 109,151,472 | 7.67% | 0.04% |
| Sept. 2, 2025 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 23638 | $2.50 | 543,339.0000 | 99,085,888 | 4.17% | 0.02% |
| July 28, 2025 | Unicycive Therapeutics, Inc. | $UNCY | Kenkare-Mitra Sara | Director | A | Stock Options | 21200 | $0.00 | 39,200.0000 | 12,302,059 | 117.78% | 0.17% |
| July 1, 2025 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | A | Common Stock | 54725 | $0.00 | 566,977.0000 | 99,085,888 | 10.68% | 0.06% |
| July 1, 2025 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | A | Employee Stock Option (right to buy) | 18250 | $0.00 | 18,250.0000 | 99,085,888 | 9999.99% | 0.02% |
| June 2, 2025 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 23890 | $1.34 | 512,252.0000 | 99,085,888 | 4.46% | 0.02% |
| March 3, 2025 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 29073 | $1.47 | 536,142.0000 | 99,085,888 | 5.14% | 0.03% |
| Dec. 2, 2024 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 26500 | $2.52 | 565,215.0000 | 0 | 4.48% | 0.00% |
| Oct. 1, 2024 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | A | Common Stock | 300000 | $0.00 | 591,715.0000 | 0 | 102.84% | 0.00% |
| Sept. 3, 2024 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 13926 | $4.88 | 291,715.0000 | 0 | 4.56% | 0.00% |
| June 3, 2024 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 13206 | $4.80 | 305,641.0000 | 0 | 4.14% | 0.00% |
| March 4, 2024 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 10169 | $6.92 | 318,847.0000 | 0 | 3.09% | 0.00% |
| Dec. 4, 2023 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 12519 | $5.56 | 329,016.0000 | 0 | 3.67% | 0.00% |
| Oct. 1, 2023 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | A | Employee Stock Option (right to buy) | 54500 | $0.00 | 54,500.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2023 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | A | Common Stock | 163600 | $0.00 | 341,535.0000 | 0 | 91.94% | 0.00% |
| Sept. 5, 2023 | Unicycive Therapeutics, Inc. | $UNCY | Kenkare-Mitra Sara | Director | A | Stock Options | 180000 | $0.00 | 180,000.0000 | 15,234,570 | 9999.99% | 1.18% |
| Sept. 5, 2023 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 6214 | $5.19 | 177,935.0000 | 0 | 3.37% | 0.00% |
| June 2, 2023 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 4092 | $6.90 | 184,149.0000 | 0 | 2.17% | 0.00% |
| March 2, 2023 | Alector, Inc. | $ALEC | Kenkare-Mitra Sara | President and Head of R&D | S | Common Stock | 10124 | $8.32 | 188,241.0000 | 0 | 5.10% | 0.00% |